Volume 17, Number 9—September 2011
Research
Intrahousehold Transmission of Pandemic (H1N1) 2009 Virus, Victoria, Australia
Table 3
Feature | No. (%) index case-patients, n = 36 | No. (%) secondary case-patients, n = 18 | p value* |
---|---|---|---|
Sign or symptom | |||
Fever | 35 (97.2) | 18 (100) | 0.67 |
Chills | 17 (47.2) | 8 (44.4) | 0.54 |
Headache | 25 (69.4) | 13 (72.2) | 0.55 |
Muscle pain | 20 (55.6) | 8 (44.4) | 0.32 |
Joint pain | 15 (41.7) | 7 (38.9) | 0.54 |
Fatigue | 30 (83.3) | 16 (88.9) | 0.46 |
Diarrhea | 8 (22.2) | 2 (11.1) | 0.28 |
Vomiting | 16 (44.4) | 2 (11.1) | 0.01 |
Upper respiratory tract symptoms |
32 (88.9) |
17 (94.4) |
0.45 |
Sign or symptom duration, d | |||
1–3 | 9 (25.0) | 2 (11.2) | 0.49 |
4–6 | 13 (36.1) | 9 (50.0) | |
7–9 | 9 (25.1) | 3 (16.7) | |
>10 |
5 (13.8) |
4 (22.2) |
|
Any medical care received |
36 (100) |
14 (77.8) |
0.01 |
Reported prevention and control measures taken | |||
Quarantine | 32 (88.9) | 15 (83.3) | 0.43 |
Antiviral prophylaxis | 0 | 1 (5.56) | 0.43 |
Antiviral treatment | 11 (33.3) | 2 (11.1) | 0.10 |
*Fisher exact test statistic used when expected value was <6.
1Current affiliation: La Trobe University, Melbourne, Victoria, Australia.
Page created: September 06, 2011
Page updated: September 06, 2011
Page reviewed: September 06, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.